Join attorneys, scientists, investors, entrepreneurs, and the Jewish National Fund community for an exclusive panel discussion with industry experts from the BioTech and Pharmaceutical sectors of Israel and Miami.

Hear about the potential COVID-19 “cure” Allocetra developed by Enlivex Therapeutics from Chief Scientific & Medical Officer Dror Mevorach during an intimate fireside chat.

The program will also include a lively discussion with a Miami & Israeli BioTech Panel featuring Isaac Litman, Founder & CEO of Neteera Technologies, Dr. Osnat Sela Tavor, CTO of Nanose Medical, and Andrew Satz, CEO of EVQLV, moderated by Meital Stavinsky, Partner at Holland & Knight. As part of the day’s program, learn about Jewish National Fund’s latest food technology endeavor from Nathan Hoffman, CEO of the upcoming Galilee Culinary Institute by JNF.

Partner, Holland & Knight

Co-Chair of Israel Practice

Chief Scientific and Medical Officer, Enlivex Therapeutics

Director Rheumatology Research Center & Chairman of Medicine, Hadassah Medical Center in Jerusalem

CEO, EVQLV

CEO, Galilee Culinary Institute by JNF

Mr. Ronald Gerstl

Author of The Super Achievers: The Remarkable Jewish Contribution to Science and Human Well-being Highlighted by Nobel Prize Winners

Mike Teichberg, Director, Miami-Dade

[email protected] or 305.682.0025 x897